Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Gynecologic Oncology
>
2020
>
31
>
6
Volume:
31
Issue:
6
1. Feasibility and safety of fertilitysparing surgery in epithelial ovarian cancer with dense adhesion: a longterm result from a single institution
Page:e85—
2. Comments on: Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study
Page:e96—
3. High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway
Page:e91—
4. Olaparib and bevacizumab in frontline maintenance of ovarian cancer: an over reliance in unpowered subgroup analysis of the PAOLA-1 trial?
Page:e95—
5. Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
Page:e92—
6. The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
Page:e94—
7. Evaluation of the optimal sequence of adjuvant chemotherapy and radiation therapy in the treatment of advanced endometrial cancer
Page:e90—
8. High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
Page:e93—
9. Reclassification of BRCA1 and BRCA2variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
Page:e83—
10. Management of stage II endometrial cancer and subsequent oncologic outcomes: a National Cancer Database study
Page:e84—
11. Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?
Page:e81—
12. Surviving the COVID-19 pandemic:early response of a gynecologic oncology unit in Singapore
Page:e77—
13. Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
Page:e78—
14. Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis
Page:e80—
15. Surgical or imaging lymph node assessment in locally advanced cervical cancer: a systematic review and meta-analysis
Page:e79—
16. Feasibility and safety of fertilitysparing surgery in epithelial ovarian cancer with dense adhesion: a longterm result from a single institution
Page:e85—
17. Comments on: Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study
Page:e96—
18. High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway
Page:e91—
19. Olaparib and bevacizumab in frontline maintenance of ovarian cancer: an over reliance in unpowered subgroup analysis of the PAOLA-1 trial?
Page:e95—
20. Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
Page:e92—
21. The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
Page:e94—
22. Evaluation of the optimal sequence of adjuvant chemotherapy and radiation therapy in the treatment of advanced endometrial cancer
Page:e90—
23. High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
Page:e93—
24. Reclassification of BRCA1 and BRCA2variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
Page:e83—
25. Management of stage II endometrial cancer and subsequent oncologic outcomes: a National Cancer Database study
Page:e84—
26. Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?
Page:e81—
27. Surviving the COVID-19 pandemic:early response of a gynecologic oncology unit in Singapore
Page:e77—
28. Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
Page:e78—
29. Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis
Page:e80—
30. Surgical or imaging lymph node assessment in locally advanced cervical cancer: a systematic review and meta-analysis
Page:e79—